Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis

Abstract

These findings support the role of IGF-I in the development of prostate cancer, including for aggressive disease.